CVS Health is a company in transition, moving away from the old pharmacy chain to an integrated healthcare giant. Read more ...

What a time it’s been for CVS Health. In the past six months alone, the company’s stock price has increased by a massive 47.6 ...

CVS Health (NYSE:CVS) snapped seven straight sessions of gains as the stock closed 0.92% lower, at $67.09 on Tuesday. The ...

CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...

Ariel Investments, an investment management company, released its “Ariel Global Fund” first-quarter 2025 investor letter. A ...

Investing.com -- CVS Health (NYSE: CVS) stock rose 1% on Wednesday after Bloomberg reported that Medicare Pharmacy Benefit Manager (PBM) limits were stripped from the Senate version of the tax bill.

Health insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year citing higher medical costs.

Ratings for CVS Health CVS were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, ...

CVS HealthCVS and The Cigna GroupCI stand as two dominant forces in the U.S. diversified healthcare sector, commanding market capitalizations of approximately $77 billion and $84 billion, respectively ...